Synergistic antitumor effect between Olaparib and Chidamide by regulation of MYBL2 in lung cancer.

Epidaza (chidamide) - Chipscreen

Lynparza (olaparib) - Merck (MSD), AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42068974

Jiaqi Xin; Lijun Ma; Lila Zhu; Rui Liu; Runshi Zhang; Ting Deng; Xia Wang; Yi Ba; Zhi Ji

May 3, 2026